RDInvesting Provides Stock Research on Trina Solar and Yingli Green Energy
Continue ReadingTag: research-reports
FDA Approved a Total of 39 New Drugs in 2012 — Fifteen Year High
Research Driven Investing Provides Stocks Research on StemCells and ZIOPHARM Oncology
Continue Reading
First Solar and SunPower Surge After Receiving “Buy” Rating From CitiGroup
RDInvesting Provides Stock Research on First Solar and SunPower
Continue Reading
Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High
Research Driven Investing Provides Stocks Research on ArQule and BioCryst Pharmaceuticals
Continue Reading
Steadily Improving U.S. Housing Market Continues to Increase Appeal of High Yielding REITs
Five Star Equities Provides Stock Research on Invesco Mortgage Capital and Two Harbors Investment
Continue Reading
For-Profit Educators Look to Benefit as Pell Grant Program Not Expected to Receive Budget Cuts
Five Star Equities Provides Stock Research on Apollo Group and Career Education
Continue Reading
High Yielding REITs Continue to Best Broader Markets in 2013
Five Star Equities Provides Stock Research on Chimera Investment and Annaly Capital Management
Continue Reading
Gaming Stocks Look to Benefit as New Jersey Close to Becoming the Third State to Legalize Online Gambling
Five Star Equities Provides Stock Research on Bally Technologies and Glu Mobile
Continue Reading
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success
Research Driven Investing Provides Stocks Research on ImmunoGen and Omeros
Continue Reading
U.S. Food and Drug Administration Approved 30% More Drugs in 2012
Research Driven Investing Provides Stocks Research on Athersys and Rexahn Pharmaceuticals
Continue Reading